Genomtec S.A. (WSE:GMT)
5.23
+0.08 (1.55%)
Jun 16, 2026, 4:48 PM CET
Genomtec Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.61 | 0.95 | 6.7 | 4.17 | 4.14 | 1.38 |
Cash & Short-Term Investments | 2.61 | 0.95 | 6.7 | 4.17 | 4.14 | 1.38 |
Cash Growth | -81.18% | -85.89% | 60.64% | 0.73% | 199.28% | -81.06% |
Accounts Receivable | 3.78 | 0.06 | 0 | 0 | 0 | 0.16 |
Other Receivables | - | 1.05 | 0.88 | 1.97 | 0.68 | 0.45 |
Receivables | 3.78 | 2 | 1.73 | 2.43 | 0.69 | 0.61 |
Inventory | - | - | - | - | 0.11 | 0.2 |
Prepaid Expenses | - | 0.16 | 0.07 | 0.05 | 0.06 | 0.06 |
Total Current Assets | 7.43 | 3.1 | 8.49 | 6.65 | 4.99 | 2.25 |
Property, Plant & Equipment | 1.68 | 0.86 | 2.61 | 1.75 | 2.19 | 1.91 |
Long-Term Investments | - | 7.86 | - | - | - | - |
Other Intangible Assets | 3.89 | - | 0 | 0.03 | 4.55 | 0.03 |
Long-Term Deferred Charges | - | - | 5.91 | 7.52 | - | - |
Other Long-Term Assets | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Total Assets | 13.03 | 11.86 | 17.04 | 15.97 | 11.76 | 4.22 |
Accounts Payable | 1.36 | 0.76 | 0.78 | 0.94 | 0.9 | 0.59 |
Accrued Expenses | - | 0.16 | 0.25 | 0.21 | 0.15 | 0.22 |
Current Portion of Long-Term Debt | - | 0.44 | 0.42 | 0.39 | 0.37 | 0.25 |
Current Portion of Leases | 1.02 | 0.46 | 0.94 | 0.49 | 0.56 | 0.65 |
Current Income Taxes Payable | - | 0.12 | 0.14 | 0.12 | 0.06 | 0.15 |
Current Unearned Revenue | - | - | 2.84 | 0.91 | 0.1 | 0.62 |
Other Current Liabilities | 1.82 | 0.11 | 0.12 | 0.09 | 0.18 | 0.09 |
Total Current Liabilities | 4.19 | 2.05 | 5.48 | 3.14 | 2.32 | 2.57 |
Long-Term Leases | 0.4 | 0.36 | 1.38 | 1.11 | 1.36 | 0.86 |
Long-Term Unearned Revenue | - | - | 2.39 | 3.3 | 3.1 | 0.06 |
Long-Term Deferred Tax Liabilities | 0.04 | 0.01 | 0.06 | 0.04 | 0.06 | 0.01 |
Other Long-Term Liabilities | 1.38 | 0.02 | 0.13 | 0.08 | 0.03 | 0.01 |
Total Liabilities | 6.01 | 2.43 | 9.44 | 7.67 | 6.87 | 3.49 |
Common Stock | 1.51 | 1.51 | 1.33 | 1.23 | 0.94 | 0.82 |
Additional Paid-In Capital | 10.35 | 10.35 | 43.37 | 32.97 | 16.86 | 9.75 |
Retained Earnings | -20.56 | -18.16 | -51.31 | -40.1 | -31.09 | -19.16 |
Comprehensive Income & Other | 15.72 | 15.72 | 14.2 | 14.2 | 18.18 | 9.31 |
Shareholders' Equity | 7.02 | 9.42 | 7.6 | 8.3 | 4.89 | 0.72 |
Total Liabilities & Equity | 13.03 | 11.86 | 17.04 | 15.97 | 11.76 | 4.22 |
Total Debt | 1.42 | 1.26 | 2.74 | 1.99 | 2.29 | 1.75 |
Net Cash (Debt) | 1.19 | -0.31 | 3.96 | 2.18 | 1.85 | -0.36 |
Net Cash Growth | -89.44% | - | 81.61% | 17.83% | - | - |
Net Cash Per Share | 0.08 | -0.02 | 0.30 | 0.18 | 0.20 | -0.04 |
Filing Date Shares Outstanding | 14.64 | 15.06 | 14.87 | 12.26 | 10.16 | 8.16 |
Total Common Shares Outstanding | 14.64 | 15.06 | 13.32 | 12.26 | 9.36 | 8.16 |
Working Capital | 3.23 | 1.05 | 3.01 | 3.5 | 2.66 | -0.31 |
Book Value Per Share | 0.48 | 0.63 | 0.57 | 0.68 | 0.52 | 0.09 |
Tangible Book Value | 3.12 | 9.42 | 7.6 | 8.27 | 0.33 | 0.7 |
Tangible Book Value Per Share | 0.21 | 0.63 | 0.57 | 0.67 | 0.04 | 0.09 |
Buildings | - | 2.33 | 2.29 | 2.15 | 1.93 | 0.96 |
Machinery | - | 0.12 | 3.34 | 1.94 | 1.91 | 1.78 |